Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6580361 | 0.81 | ALDH1A1 (0.33) | ALDH1A1LMNA | |
| SCHEMBL6578086 | 0.80 | LPAR6 (0.31) | — | |
| SCHEMBL1469963 | 0.79 | ALDH1A1 (0.35) | ALDH1A1LMNA | |
| SCHEMBL5724019 | 0.79 | CTSK (0.33) | — | |
| SCHEMBL6895950 | 0.77 | CTSK (0.39) | LMNA | |
| SCHEMBL6894951 | 0.76 | CTSK (0.38) | LMNA | |
| SCHEMBL17183127 | 0.76 | ALDH1A1 (0.34) | ALDH1A1LMNA | |
| SCHEMBL3815702 | 0.76 | TSHR (0.38) | — | |
| SCHEMBL6582472 | 0.74 | MGAM (0.39) | ALDH1A1LMNA | |
| SCHEMBL14518779 | 0.74 | ALDH1A1 (0.39) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040248941-A1 | Benzimidazone compound, process for producing the same, and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-12-09 | — | — | US | disclosed |
| EP-1437352-A1 | BENZIMIDAZOLE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2004-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248941-A1 | Benzimidazone compound, process for producing the same, and use thereof | SI, MLNR, FABP2 | ALDH1A1 698/4885LMNA 4724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.